Publications by authors named "Jia-Jian Zhong"
World J Clin Cases
September 2023
Article Synopsis
- Toripalimab and anlotinib have been approved for treating advanced esophageal cancer, showing promising efficacy in terms of response rates and progression-free survival.*
-
- A case study highlights a 73-year-old male with advanced esophageal squamous cell carcinoma who experienced a complete response after 3 months of combination therapy with these two drugs, maintaining remission for up to 14 months.*
-
- The results suggest that combining toripalimab and anlotinib could be an effective treatment option for unresectable esophageal cancer, indicating the need for further clinical trials.*
